Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind multicenter phase II trial of compound tilidine hydrochloride capsules for postoperative analgesia
CTR20130452Phase 2Completed
- Sponsor
- 河北立生药业集团
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Tilidine in postoperative pain, chronic pain, arthralgia and 3 more, sponsored by 河北立生药业集团. Primary endpoint: Pain intensity difference at 6 hours after dosing. Started May 2014; status: completed.
02
Drugs
Tilidine
03
Conditions
postoperative painchronic painarthralgiaNeuralgiacancer pain
Beyond the preview
Go deeper on CTR20130452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130452.